Your browser doesn't support javascript.
loading
A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.
Garcia-Caballero, Agustin; Gadotti, Vinicius M; Chen, Lina; Zamponi, Gerald W.
Affiliation
  • Garcia-Caballero A; Department of Physiology and Pharmacology, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Gadotti VM; Department of Physiology and Pharmacology, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Chen L; Department of Physiology and Pharmacology, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Zamponi GW; Department of Physiology and Pharmacology, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada zamponi@ucalgary.ca.
Mol Pain ; 122016.
Article in En | MEDLINE | ID: mdl-27130589
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Endopeptidases / Cell-Penetrating Peptides / Inflammation / Neuralgia Type of study: Prognostic_studies Language: En Journal: Mol Pain Year: 2016 Type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Endopeptidases / Cell-Penetrating Peptides / Inflammation / Neuralgia Type of study: Prognostic_studies Language: En Journal: Mol Pain Year: 2016 Type: Article Affiliation country: Canada